(Q43992329)

28 November 2017

title

Downregulation of apoptosis in the target tissue prevents low-dose streptozotocin-induced autoimmune diabetes (English)

1 reference

Stanislava Stosic-Grujicic

28 November 2017

author

2

1 reference

Danijela Maksimović-Ivanić

28 November 2017

3

1 reference

28 November 2017

Mensah-Brown EP

1

1 reference

28 November 2017

Jasima A

4

1 reference

28 November 2017

Shahin A

5

1 reference

28 November 2017

Lukic ML

6

1 reference

28 November 2017

publication date

1 May 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

38

1 reference

28 November 2017

issue

12-13

1 reference

28 November 2017

page(s)

941-946

1 reference

Interleukin-1 beta-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2802%2900021-4

7 January 2021

Suppression of experimental autoimmune neuritis by phosphodiesterase inhibitor pentoxifylline.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2802%2900021-4

7 January 2021

beta-cell apoptosis and defense mechanisms: lessons from type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2802%2900021-4

7 January 2021

Insulin secretion, DNA damage, and apoptosis in human and rat islets of Langerhans following exposure to nitric oxide, peroxynitrite, and cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2802%2900021-4

7 January 2021

A mouse CD8 T cell-mediated acute autoimmune diabetes independent of the perforin and Fas cytotoxic pathways: possible role of membrane TNF.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2802%2900021-4

7 January 2021

The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2802%2900021-4

7 January 2021

Inhibition of nitric oxide generation affects the induction of diabetes by streptozocin in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2802%2900021-4

7 January 2021

Effector mechanisms in low-dose streptozotocin-induced diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2802%2900021-4

7 January 2021

Pentoxifylline in the treatment of children with new-onset type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2802%2900021-4

7 January 2021

Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2802%2900021-4

7 January 2021

Effects of tumor necrosis factor and pentoxifylline on ICAM-1 expression on human polymorphonuclear granulocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2802%2900021-4

7 January 2021

Inhibition of human interleukin-12 production by pentoxifylline

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2802%2900021-4

7 January 2021

Low dose streptozotocin-induced diabetes in rat insulin promoter-mCD80-transgenic mice is T cell autoantigen-specific and CD28 dependent

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2802%2900021-4

7 January 2021

Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2802%2900021-4

7 January 2021

An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2802%2900021-4

7 January 2021

Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2802%2900021-4

7 January 2021

Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1- but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2802%2900021-4

7 January 2021

Methylxanthine-induced inhibition of the antigen- and superantigen-specific activation of T and B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2802%2900021-4

7 January 2021

Pentoxifylline modulates meningeal inflammation in experimental bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2802%2900021-4

7 January 2021

Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2802%2900021-4

7 January 2021

Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2802%2900021-4

7 January 2021

Pentoxifylline suppresses irritant and contact hypersensitivity reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2802%2900021-4

7 January 2021

Role of activated macrophages in augmentation of endotoxin hepatotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2802%2900021-4

7 January 2021

Antidiabetogenic effect of pentoxifylline is associated with systemic and target tissue modulation of cytokines and nitric oxide production.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2802%2900021-4

7 January 2021

Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2802%2900021-4

7 January 2021

Cell-specific effects of pentoxifylline on nitric oxide production and inducible nitric oxide synthase mRNA expression

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2802%2900021-4

7 January 2021

Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2802%2900021-4

7 January 2021

Nitric oxide production and Fas surface expression mediate two independent pathways of cytokine-induced murine beta-cell damage

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2802%2900021-4

7 January 2021

10.1016/S0161-5890(02)00021-4

Identifiers

DOI

1 reference

28 November 2017

1 reference